Yunzhi Essence to Improve Quality of Life in Advanced Cancer
Official title: Yunzhi Essence to Improve the Quality of Life of Patients With Advanced Stage of Cancer: A Randomized, Double-blinded, Placebo-controlled Trial
Run by Chinese University of Hong Kong · NCT05754801 · Data updated 2026-11-12
A 6‑month, randomized, placebo‑controlled test to see if Yunzhi Essence improves quality of life for people with advanced cancer receiving palliative care.
Quick facts
| Phase | Phase 2 |
|---|---|
| Study type | Interventional |
| Ages | 21 Years to 89 Years |
| Sex | All |
| Enrollment | 172 (estimated) |
| Sponsor | Chinese University of Hong Kong Academic / other |
| Locations | 1 site (Hong Kong) |
| Status | Recruiting |
| Started | January 5, 2024 |
| Main results expected | March 31, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | July 30, 2026 |
| Trial ID | NCT05754801 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults with advanced cancer eligible for palliative care, with adequate cognitive function and no known allergy to traditional Chinese medicines.
✕Probably not a fit
Patients with very limited life expectancy or inability to take oral treatments may not experience benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This phase 2 trial tests a traditional Chinese medicine product, Yunzhi Essence, versus placebo in adults with advanced cancer. Participants are randomly assigned in a double‑blind manner for six months to assess impact on quality of life and tolerability. The study uses standardized eligibility criteria including palliative prognostic assessment and cognitive screening, and follows conventional safety monitoring protocols. The product is derived from Coriolus versicolor (Yunzhi) with an aim to bolster well‑being during palliative care.
Why it matters
Potential benefit: If successful, participants may experience improved comfort and overall quality of life during advanced cancer care.
How similar studies have gone: Other randomized trials in supportive cancer care have shown potential quality‑of‑life benefits from traditional herbal products, but this specific approach is relatively novel in rigorous placebo‑controlled testing.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosed with advanced cancer according to the definition from American Cancer Society; * According to the experience of the doctor, by using Palliative Prognostic Index (score\>4), integrated with past cases and professional knowledge judged to have life expectancy not less than six months to two years; * Abbreviated mental test (AMT) score of 6 or above; * Voluntarily participate in this clinical trial and sign the informed consent form (acceptance of close relatives signed informed consent on behalf of the patient); * Refer to the national standard for Clinic terminology of traditional Chinese medical diagnosis and treatment-Part 2:Syndromes/patterns, syndrome of "damp heat spleen" and "spleen deficiency with water stop" (Fulfill 2 of the main symptoms and 2 of the secondary symptoms). Exclusion Criteria: * Patients with a history of allergy to traditional Chinese medicine or Yunzhi; * Patients who required nasal feeding or difficulty swallowing; * Patients with comatose/semi-conscious, cognitively impaired with dementia/confusion, physically too ill with extremely poor general condition, or there was a language barrier.
Where it's running
-
School of Chinese Medicine
Hong Kong, Hong Kong Recruiting
Study contacts
- Principal investigator: Zhixiu Lin — Hong Kong Institute of Integrative Medicine
- Study coordinator: Cho Wing Lo
- Email: louislo@cuhk.edu.hk
- Phone: 35053476
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Prehospital end-of-life care: how professionals use a comfort care booklet in Strasbourg
This study tests how emergency crew members in Strasbourg use a comfort care booklet when caring for patients at end of life, and what they think about it.
-
Concise coaching to guide decisions for advanced cancer patients considering palliative procedures
A coaching program delivered by lay providers will test whether it helps adults with advanced cancer make better, patient-aligned decisions about palliative surgeries or similar interventions.
-
Primary Palliative Care: A Feasibility Project for Family Health Units
This feasibility trial tests a GP training program plus a structured 12-week palliative-care visit plan to see if it can be carried out in primary care for adults with advanced illness.
-
Relaxation and breathing techniques to help with breathlessness and tiredness in cancer patients in palliative care
This study tests whether progressive muscle relaxation or deep breathing exercises can reduce dyspnea and fatigue and improve self-care in adults with cancer receiving palliative care.
-
Relief of dyspnea with high-flow nasal therapy in palliative care
This study tests whether high-flow nasal therapy helps relieve breathlessness in adults receiving palliative care.
-
Palliative and supportive care to help people with inflammatory arthritis live well
This project will see how palliative and supportive care could help adults with inflammatory arthritis live better throughout their illness.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.